SHPH Financials

Income Statement
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
2.2M
-20.5%
2.8M
+23.0%
2.3M
-42.0%
3.9M
+32.5%
3.0M
R&D
267.2K
-47.8%
511.9K
-45.7%
943.5K
-8.0%
1.0M
-34.8%
1.6M
SG&A
1.2M
-37.0%
1.8M
+108.1%
886.1K
-62.2%
2.3M
+293.1%
596.9K
Operating Income
-2216822
+20.5%
-2788235
-23.0%
-2266942
+42.0%
-3910406
-32.5%
-2951241
EBITDA
-794456
+61.6%
-2066338
-13.0%
-1828525
+45.8%
-3372849
-55.4%
-2169806
Net Income
-2152471
+17.7%
-2614895
-11.4%
-2347302
+36.7%
-3706465
-21.4%
-3053007
EPS (Basic)
$-4.30
+54.1%
$-9.37
+10.8%
$-10.50
+68.1%
$-32.90
+56.7%
$-76.00
EPS (Diluted)
$-4.30
+54.1%
$-9.37
+10.8%
$-10.50
+68.1%
$-32.90
+56.7%
$-76.00
Shares (Diluted)
503.2K
+80.3%
279.0K
+24.9%
223.4K
+98.4%
112.6K
+180.1%
40.2K
Shuttle Pharmaceuticals (SHPH) โ€” Financials